Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: A pilot study

Journal of Pain and Symptom Management

Volumn 28, Issue 6, 2004, Pages 619-625

  Fisher, Kim ^a   Stiles, Carla ^a   Hagen, Neil A ^a,b  

^a Alberta Cancer Bd Palliative R   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

Author keywords

breakthrough pain; cancer; incident pain; Methadone; oral administration

Indexed keywords

AMANTADINE; CAPSAICIN; DEXAMETHASONE; FENTANYL; FENTANYL CITRATE; GABAPENTIN; HYDROMORPHONE; IMIPRAMINE; METHADONE; MORPHINE SULFATE; OPIATE; PARACETAMOL; ROFECOXIB;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MALE; PAIN ASSESSMENT; SATISFACTION; SIDE EFFECT;

EID: 10344222128     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2004.03.003     Document Type: Short Survey

References (26)

1. R.K. Portenoy, and N.A. Hagen Breakthrough pain: definition, prevalence and characteristics Pain 41 1990 273 281
2. P.G. Fine, and M.A. Busch Characterization of breakthrough pain by hospice patients and their caregivers J Pain Symptom Manage 16 1998 179 183
3. B.V. Fortner, T.A. Okon, and R.K. Portenoy A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain J Pain 3 2002 38 44
4. X. Gómez-Batiste, F. Madrid, and F. Moreno Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain J Pain Symptom Manage 24 2002 45 52
5. F. Petzke, L. Radbruch, D. Zech, G. Loick, and S. Grond Temporal presentation of chronic cancer pain: Transitory pains on admission to a multidisciplinary pain clinic J Pain Symptom Manage 17 1999 391 401
6. R.K. Portenoy, D. Payne, and P. Jacobson Breakthrough pain: characteristics and impact in patients with cancer pain Pain 81 1999 129 134
7. M. Swanwick, M. Haworth, and R.F. Lennard The prevalence of episodic pain in cancer: a survey of hospice patients on admission Palliat Med 15 2001 9 18
8. G. Zeppetella, C.A. O'Doherty, and S. Collins Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice J Pain Symptom Manage 20 2000 87 92
9. B.V. Fortner, G. Demarco, and G. Irving Description and predictors of direct and indirect costs of pain reported by cancer patients J Pain Symptom Manage 25 2003 9 18
10. S.S. Hwang, V.T. Chang, and B. Kasimis Cancer breakthrough pain characteristics and responses to treatment at a VA medical center Pain 101 2003 55 64
11. J.F. Cleary Pharmacokinetic and pharmacodynamic issues in the treatment of breakthrough pain Sem Oncol 24 1997 S16-13 S16-19
12. S. Mercadante, and E. Arcuri Breakthrough pain in cancer patients: pathophysiology and treatment Cancer Treat Rev 24 1998 425 432
13. S. Mercadante, L. Radbruch, and A. Caraceni Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care Cancer 94 2002 832 839
14. R.B. Patt, and N.M. Ellison Breakthrough pain in cancer patients: characteristics, prevalence, and treatment Oncology 12 1998 1035 1052
15. R.K. Portenoy Treatment of temporal variations in chronic cancer pain Sem Oncol 24 1997 S16-7 S16-12
16. E. Bruera, and C. Sweeney Methadone use in cancer patients with pain: a review J Palliat Med 5 2002 127 138
17. M. Davis, and D. Walsh Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration Support Care Cancer 9 2001 73 83
18. P. Manfredi, D. Borsook, S. Chandler, and R. Payne Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations Pain 70 1997 99 101
19. J.S. Morley, and M.K. Makin The use of methadone in cancer pain poorly responsive to other opioids Pain Rev 5 1998 51 58
20. C. Scholes, N. Gotmy, and I. Trotman Methadone titration in opioid resistant cancer pain Eur J Cancer Care 8 1999 26 29
21. G.K. Gourlay, D.A. Cherry, and M.J. Cousins A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer Pain 25 1986 297 312
22. World Health Organization Cancer pain relief with a guide to opioid availability 2nd Edition 1996 World Health Organization Geneva
23. S.L. Collins, C.C. Faura, R.A. Moore, and H.J. McQuay Peak plasma concentrations after oral morphine: a systematic review J Pain Symptom Manage 16 1998 388 402
24. C.E. Inturrisi, R.K. Portenoy, M.B. Max, W.A. Colburn, and K.M. Foley Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain Clin Pharmacol Ther 47 1990 565 577
25. C.E. Inturrisi, W.A. Colburn, R.F. Kaiko, R.W. Houde, and K.M. Foley Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain Clin Pharmacol Ther 41 1987 392 401
26. J.T. Farrar, J. Cleary, R. Rauch, M. Busch, and E. Nordbrock Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients J Nat Canc Inst 90 1998 611 616